Clinical Trials Logo

Post-polycythemia Vera Myelofibrosis (Post-PV MF) clinical trials

View clinical trials related to Post-polycythemia Vera Myelofibrosis (Post-PV MF).

Filter by:
  • None
  • Page 1

NCT ID: NCT03441113 Enrolling by invitation - Clinical trials for Primary Myelofibrosis (PMF)

Extended Access of Momelotinib in Adults With Myelofibrosis

Start date: May 3, 2018
Phase: Phase 2
Study type: Interventional

The primary objective of this study is to provide extended access of momelotinib (MMB) in participants with primary myelofibrosis (PMF) or post-polycythemia vera or post-essential thrombocythemia myelofibrosis (Post-PV/ET MF) enrolled in Gilead sponsored studies GS-US-352-0101 (NCT01969838), GS-352-1214 (NCT02101268), GS-US-352-1154 (NCT02124746), who are currently receiving treatment with MMB (available as 100 mg, 150 mg and 200 mg tablets) and have not experienced progression of disease.